SCHEMBL1122873

SCHEMBL1122873

CCOC(=O)CN(Cc1cccc(OCc2ccccc2)c1)C(=O)c1ccc(OCCOc2nc3ccccc3nc2C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 7/20 0.45
SLC2A4 P14672 1/20 0.45
MEN1 O00255 1/20 0.44
HSP90AA1 P07900 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
PPARG P37231 2/20 0.43
PPARA Q07869 2/20 0.43
PTGES O14684 2/20 0.42
ALOX5 P09917 1/20 0.41
LTC4S Q16873 1/20 0.41
CYSLTR2 Q9NS75 1/20 0.41
CYSLTR1 Q9Y271 1/20 0.41
NPC1 O15118 2/20 0.40
LMNA P02545 2/20 0.40
RAB9A P51151 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
PPARD Q03181 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123226 0.95 L3MBTL1 (0.43) SLC2A1SLC2A4MEN1HSP90AA1KMT2A
SCHEMBL1122802 0.93 L3MBTL1 (0.47) MEN1HSP90AA1KMT2AL3MBTL1PPARG
SCHEMBL1123219 0.92 CYSLTR2 (0.45) SLC2A1SLC2A4MEN1HSP90AA1KMT2A
SCHEMBL1123430 0.92 PPARA (0.49) SLC2A1SLC2A4L3MBTL1PPARGPPARA
SCHEMBL5720728 0.87 CYSLTR2 (0.45) SLC2A1SLC2A4MEN1HSP90AA1KMT2A
SCHEMBL1122770 0.87 SLC2A1 (0.46) SLC2A1SLC2A4MEN1HSP90AA1KMT2A
SCHEMBL1122793 0.86 L3MBTL1 (0.47) SLC2A1SLC2A4KMT2AL3MBTL1PPARG
SCHEMBL1123229 0.86 SLC2A1 (0.55) SLC2A1SLC2A4MEN1KMT2APTGES
SCHEMBL1123269 0.84 L3MBTL1 (0.50) MEN1KMT2AL3MBTL1PPARGPPARA
SCHEMBL1123108 0.82 L3MBTL1 (0.45) SLC2A1SLC2A4KMT2AL3MBTL1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG SLC2A1 2494/4885SLC2A4 2363/4885MEN1 4877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.